A retrospective study of arthroscopic treatment for patients with bordline developmental dysplasia of the hip

Purpose Hip arthroscopy is effective in treating bordline developmental dysplasia of the hip (BDDH), but there are only a few clinical reports in China, and its postoperative failure rate is still a problem that cannot be ignored. The aim of this study was to analyze the clinical effect of hip arthr...

Full description

Saved in:
Bibliographic Details
Published in:International orthopaedics 2024-11, Vol.48 (11), p.2843-2852
Main Authors: Gou, Yu, Zhang, Zi, Meng, Binyang, Cao, Jiangang, Zhu, Jiawang, Li, Hongzhou, Zhao, Qian
Format: Article
Language:English
Subjects:
Activities of Daily Living
Adult
Arthroscopy - methods
China - epidemiology
Developmental Dysplasia of the Hip - surgery
Female
Hip Joint - surgery
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Original Paper
Orthopedics
Retrospective Studies
Treatment Outcome
Young Adult
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Hip arthroscopy is effective in treating bordline developmental dysplasia of the hip (BDDH), but there are only a few clinical reports in China, and its postoperative failure rate is still a problem that cannot be ignored. The aim of this study was to analyze the clinical effect of hip arthroscopy in BDDH treatment in China and to explore the risk factors influencing the efficacy of hip arthroscopy in BDDH treatment. Methods All of 22 cases of BDDH treated with arthroscopy in our hospital from November March 2017 to February 2022 were analyzed retrospectively, including ten males and 12 females, with an average age of 34.7 ± 9.5 years (19–53 years). All patients underwent arthroscopic treatment with acetabular plasty, labral repair, femoral osteoplasty, and capsular plication. Visual Analogue Scale (VAS), modified Harris Hip Scores (mHHS), Hip Outcome Score—activities of Daily Living (HOS-ADL) and International Hip Outcome Tool-12 (iHOT-12) were measured before operation and at the follow-up, and statistical analysis was performed. The Minimum clinically significant difference (MCID) and Patient Acceptable Symptom State (PASS) were also obtained. Results 22 patients were followed up, and the follow-up time was ≥ one year, with an average of 21.4 ± 8.2 months. The VAS score decreased from 5.27 ± 1.58 points before surgery to 1.96 ± 0.92 points at the follow-up, and the difference was statistically significant ( t = 9.05 , P  
ISSN:0341-2695
1432-5195
1432-5195
DOI:10.1007/s00264-024-06300-7